Deep brain stimulation to improve walking in patients with incomplete spinal cord injury
Official title: A Phase I/II Open-label Multicenter Trial to Evaluate Safety and Preliminary Efficacy of Unilateral Deep Brain Stimulation of the Mesencephalic Locomotor Region in Patients With Incomplete Spinal Cord Injury
Run by University of Zurich · NCT03053791 · Data updated 2026-11-12
This study is testing if a new brain stimulation treatment can help people with incomplete spinal cord injuries walk better and improve their quality of life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | University of Zurich Academic / other |
| Locations | 1 site (Zurich) |
| Status | Recruiting |
| Started | March 15, 2018 |
| Main results expected | December 2026 |
| Study ends | December 2027 |
| Registry record updated | May 29, 2026 |
| Trial ID | NCT03053791 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18-75 with motor incomplete spinal cord injuries who have completed rehabilitation and can walk with assistance.
✕Probably not a fit
Patients with complete spinal cord injuries or those who do not meet the specific inclusion criteria may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the safety and preliminary efficacy of unilateral deep brain stimulation (DBS) targeting the mesencephalic locomotor region in patients with incomplete spinal cord injuries. Participants, aged 18-75, who have completed in-patient rehabilitation and are at least three months post-injury, will undergo DBS implantation. The primary goal is to assess improvements in locomotion using the 6-Minute walking test, alongside secondary evaluations of quality of life and other health metrics over a six-month period. The study aims to explore a novel approach to enhance mobility in individuals who currently have limited treatment options.
Why it matters
Potential benefit: If successful, this approach could significantly improve mobility and quality of life for patients with incomplete spinal cord injuries.
How similar studies have gone: While deep brain stimulation has shown promise in other movement disorders, this specific application for incomplete spinal cord injury is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Informed Consent 2. Participation in two assessment sessions before enrollment (Screening and baseline) 3. Willingness and ability to comply with the protocol and to attend required study training and visits 4. Male or female subjects 5. Age 18-75 6. Motor incomplete SCI 7. Level of lesion: T10 and above, based on AIS level, preservation of sacral function 8. Focal spinal cord disorder caused by either trauma or non-traumatic and non-progressive condition (like hemorrhage, benign tumor) 9. Minimum 3 months of recovery after SCI 10. Completed in-patient rehabilitation program 11. WISCI II, level \>2 (0-20 items): assistance of one or more persons. Ability to walk at least 10 meters 12. Stable medical and physical condition. 13. Adequate care-giver support and access to appropriate medical care in patient's home community Exclusion Criteria: 1. Enrollment of the investigator, his/her family members, employees and other dependent persons 2. Limitation of standing and walking function based on accompanying (CNS) disorders 3. Cardiovascular disorders restricting physical training or peripheral nerve disorders 4. Implanted technical devices (pacemaker, defibrillator) 5. History of significant autonomic dysreflexia 6. Cognitive disorders/brain damage 7. Drug refractory epilepsy 8. Severe joint contractures disabling or restricting lower limb movements 9. Haematological disorders with increased risk of bleeding during surgical interventions 10. Participation in another study with investigational drug within the 30 days preceding and during the present study 11. Congenital or acquired lower limb abnormalities (affection of joints and bone) 12. Women who are pregnant or breast feeding or planning a pregnancy during the course of the study 13. Lack of safe contraception 14. Inability of the participant to follow the procedures of the study, e.g. due to language problems, psychological problems, dementia etc. 15. Known or suspected non-compliance, drug or alcohol abuse 16. Current or prior malignancy
Where it's running
-
Balgrist University Hospital
Zurich, Switzerland Recruiting
Study contacts
- Principal investigator: Lennart H Stieglitz, MD — University Hospital Zurich, Neurosurgery
- Study coordinator: Lennart H Stieglitz, MD
- Email: Lennart.Stieglitz@usz.ch
- Phone: +4144255
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Implanted Brain-Computer Interface to Help People with Severe Arm Impairment
We’re testing the N1 System, a fully implanted brain interface in the motor cortex with a robot, to see if it can help adults with spinal cord injury, ALS, or chronic stroke use a computer or keyboard more easily.
-
tSCS with rehabilitation for improving movement after spinal cord injury
This study tests whether adding rehabilitation training to transcutaneous spinal cord stimulation helps paraplegic patients regain voluntary movement after spinal cord injury.
-
Informational Needs of Caregivers of Patients in Neuro Rehab: Validating the QBI-R/V
This study tests a caregiver questionnaire (QBI-R and QBI-V) to see how well it measures caregivers’ informational needs during neuromotor rehabilitation.
-
Biomechanical and Perceived Effort in Manual Wheelchair Propulsion
This study tests whether combining objective shoulder loading data with how hard people feel they’re working can reveal how difficult manual wheelchair propulsion is for users with spinal cord injury.
-
Shockwave therapy added to toxin injections to help spasticity after spinal cord injury
Aims to see if focused shockwave therapy plus Botox injections reduce spasticity better than Botox alone in adults with spinal cord injury.
-
Vibratory Genital Nerve Stimulation to Help Female Sexual Function After Spinal Cord Injury
This study tests whether a home-use vibration device can improve sexual function in cisgender women with spinal cord injury by increasing genital blood flow during arousal.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.